Advertisement
Screener

ARTIVION, INC. (AORT) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ARTIVION, INC. Operating Cash Flow

ARTIVION, INC. (AORT) reported Operating Cash Flow of -$112.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07

  • ARTIVION, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.27M, a 108.43% decline year-over-year.
  • ARTIVION, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $1.15M.
  • ARTIVION, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $19.56M, a 92.92% increase year-over-year.
  • ARTIVION, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $22.26M, a 94.34% increase year-over-year.
  • ARTIVION, INC. net cash provided by (used in) operating activities for fiscal 2025 was $39.88M, a 79.35% increase from fiscal 2024.
  • ARTIVION, INC. net cash provided by (used in) operating activities for fiscal 2024 was $22.24M, a 18.12% increase from fiscal 2023.
  • ARTIVION, INC. net cash provided by (used in) operating activities for fiscal 2023 was $18.82M.
  • ARTIVION, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$5.15M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30-$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$112.00K
10-Q · filed 2026-08-07
$19.45M
derived: sum of 3 quarters · filed 2026-08-07
$41.71M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$1.15M
10-Q · filed 2026-05-08
$20.71M
derived: sum of 2 quarters · filed 2026-05-08
$42.98M
derived: sum of 3 quarters · filed 2026-05-08
$57.99M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$19.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$41.82M
derived: sum of 2 quarters · filed 2026-02-18
$56.83M
derived: sum of 3 quarters · filed 2026-08-07
$39.88M
10-K · filed 2026-02-18
2025-09-30$22.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$37.27M
derived: sum of 2 quarters · filed 2026-08-07
$20.32M
10-Q · filed 2025-11-07
$30.46M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$15.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$1.94M
10-Q · filed 2026-08-07
$8.20M
derived: sum of 3 quarters · filed 2026-08-07
$19.65M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$16.95M
10-Q · filed 2026-05-08
-$6.81M
derived: sum of 2 quarters · filed 2026-05-08
$4.64M
derived: sum of 3 quarters · filed 2026-05-08
$10.78M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$10.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$21.59M
derived: sum of 2 quarters · filed 2026-02-18
$27.73M
derived: sum of 3 quarters · filed 2026-02-18
$22.24M
10-K · filed 2026-02-18
2024-09-30$11.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$17.59M
derived: sum of 2 quarters · filed 2025-11-07
$12.10M
10-Q · filed 2025-11-07
$22.93M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-30$6.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$642.00K
10-Q · filed 2025-08-08
$11.48M
derived: sum of 3 quarters · filed 2026-02-18
$18.71M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-31-$5.49M
10-Q · filed 2025-05-06
$5.34M
derived: sum of 2 quarters · filed 2026-02-18
$12.58M
derived: sum of 3 quarters · filed 2026-02-18
$19.49M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-31$10.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$18.07M
derived: sum of 2 quarters · filed 2026-02-18
$24.98M
derived: sum of 3 quarters · filed 2026-02-18
$18.82M
10-K · filed 2026-02-18
2023-09-30$7.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$14.14M
derived: sum of 2 quarters · filed 2024-11-08
$7.99M
10-Q · filed 2024-11-08
$7.77M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$6.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$755.00K
10-Q · filed 2024-08-09
$538.00K
derived: sum of 3 quarters · filed 2025-02-28
$4.51M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$6.15M
10-Q · filed 2024-05-07
-$6.37M
derived: sum of 2 quarters · filed 2025-02-28
-$2.40M
derived: sum of 3 quarters · filed 2025-02-28
-$10.71M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$217.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$3.76M
derived: sum of 2 quarters · filed 2025-02-28
-$4.55M
derived: sum of 3 quarters · filed 2025-02-28
-$5.15M
10-K · filed 2025-02-28
2022-09-30$3.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
-$4.34M
derived: sum of 2 quarters · filed 2023-11-03
-$4.94M
10-Q · filed 2023-11-03
-$4.22M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30-$8.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$8.91M
10-Q · filed 2023-08-04
-$8.20M
derived: sum of 3 quarters · filed 2024-02-23
-$11.11M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31-$598.00K
10-Q · filed 2023-05-05
$118.00K
derived: sum of 2 quarters · filed 2024-02-23
-$2.79M
derived: sum of 3 quarters · filed 2024-02-23
-$144.00K
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$716.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
-$2.19M
derived: sum of 2 quarters · filed 2024-02-23
$454.00K
derived: sum of 3 quarters · filed 2024-02-23
-$2.58M
10-K · filed 2024-02-23
2021-09-30-$2.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
-$262.00K
derived: sum of 2 quarters · filed 2022-11-04
-$3.30M
10-Q · filed 2022-11-04
$2.15M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$2.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$392.00K
10-Q · filed 2022-08-05
$5.06M
derived: sum of 3 quarters · filed 2023-02-23
$12.74M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$3.04M
10-Q · filed 2022-05-06
$2.41M
derived: sum of 2 quarters · filed 2023-02-23
$10.09M
derived: sum of 3 quarters · filed 2023-02-23
$6.70M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$5.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$13.13M
derived: sum of 2 quarters · filed 2023-02-23
$9.73M
derived: sum of 3 quarters · filed 2023-02-23
$12.37M
10-K · filed 2023-02-23
2020-09-30$7.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$4.28M
derived: sum of 2 quarters · filed 2021-11-05
$6.92M
10-Q · filed 2021-11-05
$7.98M
derived: sum of 4 quarters · filed 2022-02-22
2020-06-30-$3.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$760.00K
10-Q · filed 2021-07-30
$300.00K
derived: sum of 3 quarters · filed 2022-02-22
$13.16M
derived: sum of 4 quarters · filed 2022-02-22
2020-03-31$2.63M
10-Q · filed 2021-04-30
$3.69M
derived: sum of 2 quarters · filed 2022-02-22
$16.55M
derived: sum of 3 quarters · filed 2022-02-22
$17.30M
derived: sum of 4 quarters · filed 2022-02-22
2019-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22
$13.92M
derived: sum of 2 quarters · filed 2022-02-22
$14.67M
derived: sum of 3 quarters · filed 2022-02-22
$15.83M
10-K · filed 2022-02-22
2019-09-30$12.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$13.61M
derived: sum of 2 quarters · filed 2020-11-05
$14.77M
10-Q · filed 2020-11-05
$25.29M
derived: sum of 4 quarters · filed 2021-02-23
2019-06-30$746.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$1.91M
10-Q · filed 2020-07-31
$12.43M
derived: sum of 3 quarters · filed 2021-02-23
$20.75M
derived: sum of 4 quarters · filed 2021-02-23
2019-03-31$1.16M
10-Q · filed 2020-05-01
$11.68M
derived: sum of 2 quarters · filed 2021-02-23
$20.00M
derived: sum of 3 quarters · filed 2021-02-23
$20.77M
derived: sum of 4 quarters · filed 2021-02-23
2018-12-31$10.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23
$18.84M
derived: sum of 2 quarters · filed 2021-02-23
$19.61M
derived: sum of 3 quarters · filed 2021-02-23
$9.88M
10-K · filed 2021-02-23
2018-09-30$8.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$9.09M
derived: sum of 2 quarters · filed 2019-10-31
-$640.00K
10-Q · filed 2019-10-31
$5.34M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$767.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$8.96M
10-Q · filed 2019-07-31
-$2.98M
derived: sum of 3 quarters · filed 2020-02-19
-$179.00K
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31-$9.73M
10-Q · filed 2019-05-02
-$3.75M
derived: sum of 2 quarters · filed 2020-02-19
-$946.00K
derived: sum of 3 quarters · filed 2020-02-19
-$2.79M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$5.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$8.78M
derived: sum of 2 quarters · filed 2020-02-19
$6.93M
derived: sum of 3 quarters · filed 2020-02-19
$10.80M
10-K · filed 2020-02-19
2017-09-30$2.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$957.00K
derived: sum of 2 quarters · filed 2018-11-01
$4.83M
10-Q · filed 2018-11-01
2017-06-30-$1.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$2.02M
10-Q · filed 2018-08-07
2017-03-31$3.87M
10-Q · filed 2018-05-04
2016-12-31$19.72M
10-K · filed 2019-02-26
2015-12-31$11.44M
10-K · filed 2018-03-09
2013-09-30$7.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29
$12.48M
derived: sum of 2 quarters · filed 2013-10-29
$11.31M
10-Q · filed 2013-10-29
$19.29M
derived: sum of 4 quarters · filed 2013-10-29
2013-06-30$5.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25
$4.04M
10-Q · filed 2013-07-25
$12.02M
derived: sum of 3 quarters · filed 2013-07-25
$18.10M
derived: sum of 4 quarters · filed 2013-10-29
2013-03-31-$1.17M
10-Q · filed 2013-04-30
$6.81M
derived: sum of 2 quarters · filed 2013-04-30
$12.89M
derived: sum of 3 quarters · filed 2013-10-29
$16.02M
derived: sum of 4 quarters · filed 2013-10-29
2012-12-31$7.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$14.06M
derived: sum of 2 quarters · filed 2013-10-29
$17.18M
derived: sum of 3 quarters · filed 2013-10-29
$18.99M
10-K · filed 2013-02-15
2012-09-30$6.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29
$9.20M
derived: sum of 2 quarters · filed 2013-10-29
$11.01M
10-Q · filed 2013-10-29
$14.05M
derived: sum of 4 quarters · filed 2013-10-29
2012-06-30$3.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25
$4.93M
10-Q · filed 2013-07-25
$7.97M
derived: sum of 3 quarters · filed 2013-07-25
$13.79M
derived: sum of 4 quarters · filed 2013-07-25
2012-03-31$1.80M
10-Q · filed 2013-04-30
$4.85M
derived: sum of 2 quarters · filed 2013-04-30
$10.66M
derived: sum of 3 quarters · filed 2013-04-30
$14.69M
derived: sum of 4 quarters · filed 2013-04-30
2011-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$8.86M
derived: sum of 2 quarters · filed 2013-02-15
$12.88M
derived: sum of 3 quarters · filed 2013-02-15
$16.75M
10-K · filed 2013-02-15
2011-09-30$5.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30
$9.84M
derived: sum of 2 quarters · filed 2012-10-30
$13.71M
10-Q · filed 2012-10-30
$20.72M
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30$4.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31
$7.89M
10-Q · filed 2012-07-31
$14.91M
derived: sum of 3 quarters · filed 2013-02-15
$18.69M
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$3.87M
10-Q · filed 2012-04-26
$10.88M
derived: sum of 2 quarters · filed 2013-02-15
$14.66M
derived: sum of 3 quarters · filed 2013-02-15
2010-12-31$7.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$10.80M
derived: sum of 2 quarters · filed 2013-02-15
$20.84M
10-K · filed 2013-02-15
2010-09-30$3.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27
$13.82M
10-Q · filed 2011-10-27
2010-06-30$10.04M
10-Q · filed 2011-07-29
2009-12-31$16.57M
10-K · filed 2012-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92